SCHEMBL4097609

SCHEMBL4097609

COc1ccc(C(=O)c2ccc(OCCOc3ccc(C)cc3)cc2)c(OC(C)(C)C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.52
PPARG P37231 7/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
POLB P06746 1/20 0.47
MAPT P10636 3/20 0.47
HTT P42858 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
LMNA P02545 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4107824 0.91 NPC1 (0.58) NPC1PPARGPPARDPPARAPOLB
Trifluoroacetic Acid SCHEMBL4103725 0.87 PPARA (0.40) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4097793 0.86 PPARG (0.64) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4096710 0.84 PPARG (0.48) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4107394 0.83 PPARG (0.63) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4103340 0.83 KDM4E (0.47) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4099680 0.83 PPARG (0.55) NPC1PPARGPPARDPPARAMAPT
SCHEMBL4106819 0.83 PPARG (0.47) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4098495 0.83 RAB9A (0.55) NPC1PPARGPPARDPPARAPOLB
SCHEMBL4092775 0.83 POLB (0.52) NPC1PPARGPPARDPPARAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054435-A1 Phenoxyalkanoic Acid Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-26 US disclosed
EP-1911738-A1 PHENOXYALKANOIC ACID COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054435-A1 Phenoxyalkanoic Acid Compound PNLIP, GPR119, LIPC NPC1 170/4885PPARG 23/4885PPARD 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.